PL2981270T3 - Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym - Google Patents

Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym

Info

Publication number
PL2981270T3
PL2981270T3 PL14780343T PL14780343T PL2981270T3 PL 2981270 T3 PL2981270 T3 PL 2981270T3 PL 14780343 T PL14780343 T PL 14780343T PL 14780343 T PL14780343 T PL 14780343T PL 2981270 T3 PL2981270 T3 PL 2981270T3
Authority
PL
Poland
Prior art keywords
deoxy
monosaccharides
esters
proliferative activity
anti proliferative
Prior art date
Application number
PL14780343T
Other languages
English (en)
Inventor
Waldemar Priebe
Marcin Cybulski
Izabela Fokt
Stanislaw Skora
Charles Conrad
Tomothy MADDEN
Original Assignee
Board Of Regents, The University Of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Board Of Regents, The University Of Texas System filed Critical Board Of Regents, The University Of Texas System
Publication of PL2981270T3 publication Critical patent/PL2981270T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL14780343T 2013-04-05 2014-04-04 Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym PL2981270T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361809110P 2013-04-05 2013-04-05
PCT/US2014/032942 WO2014165736A2 (en) 2013-04-05 2014-04-04 Esters of 2-deoxy-monosaccharides with anti proliferative activity
EP14780343.1A EP2981270B1 (en) 2013-04-05 2014-04-04 Esters of 2-deoxy-monosaccharides with anti proliferative activity

Publications (1)

Publication Number Publication Date
PL2981270T3 true PL2981270T3 (pl) 2022-05-09

Family

ID=51659460

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14780343T PL2981270T3 (pl) 2013-04-05 2014-04-04 Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym

Country Status (7)

Country Link
US (3) US10201554B2 (pl)
EP (2) EP3939595A1 (pl)
JP (1) JP6545660B2 (pl)
ES (1) ES2897699T3 (pl)
HU (1) HUE056881T2 (pl)
PL (1) PL2981270T3 (pl)
WO (1) WO2014165736A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3939595A1 (en) 2013-04-05 2022-01-19 Board of Regents, The University of Texas System Esters of 2-deoxy-monosaccharides with anti proliferative activity
WO2020097600A1 (en) * 2018-11-09 2020-05-14 Rmd Sciences Inc. Compositions for the treatment of cancer and other conditions

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103197A (en) 1980-01-21 1981-08-18 Wakamoto Pharmaceut Co Ltd Novel d-glucose derivative and antitumor agent containing the same as active constitutent
JPS58167582A (ja) 1982-03-29 1983-10-03 Takeda Chem Ind Ltd 糖ケタ−ルの製造法
US6319695B1 (en) 1991-10-15 2001-11-20 The Scripps Research Insitute Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
ID16479A (id) 1995-06-23 1997-10-02 Oxford Glycosciences Uk Ltd Senyawa-senyawa pengobatan
DE19631221C2 (de) 1996-08-02 1999-07-01 Beiersdorf Ag Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen
EE200200565A (et) 2000-03-31 2004-06-15 Angiogene Pharmaceuticals Ltd. Vaskulaarse kahjustava toimega kombinatsioonravi
US6670330B1 (en) 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose
CA2317305A1 (en) 2000-08-29 2002-02-28 Tassos P. Anastassiades Method of enhancing chondrocyte cell growth and glycosaminoglycan production
EP1401484A1 (en) 2001-06-11 2004-03-31 Transition Therapeutics Inc. Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases
WO2003018598A2 (en) 2001-08-30 2003-03-06 University College Dublin Monosaccharide derivatives
US7001888B2 (en) 2002-03-29 2006-02-21 Threshold Pharmaceuticals, Inc. Compositions and methods for treating cancer
DE10231370B4 (de) 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
MXPA05007382A (es) 2003-01-10 2005-11-23 Threshold Pharmaceuticals Inc Tratamiento de cancer con 2-desoxiglucosa.
CA2431425A1 (en) 2003-06-05 2004-12-05 Angiogene, Inc. Epas1 gene transfer to improve cell therapy
US20050143336A1 (en) 2003-12-30 2005-06-30 Board Of Regents, The University Of Texas System Methods and compositions for improved non-viral gene therapy
WO2006024490A2 (en) 2004-08-30 2006-03-09 Interstitial Therapeutics Methods and compositions for the treatment of cell proliferation
WO2007000882A1 (ja) 2005-06-28 2007-01-04 Pioneer Corporation 妨害波検出装置および妨害波除去装置
AU2007220777A1 (en) * 2006-02-24 2007-09-07 Board Of Regents, The University Of Texas System Hexose compounds to treat cancer
US8242167B2 (en) 2006-02-24 2012-08-14 University Of Miami Mannose derivatives for killing tumor cells
FR2899588B1 (fr) 2006-04-07 2009-02-27 Oreal Utilisation de compose c-glycoside derive de galactose comme agent activateur et regulateur de l'immunite cutanee
US9149489B2 (en) 2006-04-27 2015-10-06 Board Of Regents, University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
WO2009108926A1 (en) 2008-02-29 2009-09-03 Board Of Regents, The University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
EP1881000A1 (en) 2006-07-17 2008-01-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents
WO2008131024A1 (en) 2007-04-17 2008-10-30 Board Of Regents, The University Of Texas System Iodo-hexose compounds useful to treat cancer
ES2628180T3 (es) * 2008-07-11 2017-08-02 Board Of Regents, The University Of Texas System Nuevos acetatos de 2-desoxi monosacáridos con actividad anticancerosa
CA2824175A1 (en) * 2011-01-11 2012-07-19 The University Of Texas M.D. Anderson Cancer Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
WO2012142615A2 (en) 2011-04-14 2012-10-18 Board Of Regents, The University Of Texas System Auranofin and auranofin analogs useful to treat proliferative disease and disorders
EP3939595A1 (en) 2013-04-05 2022-01-19 Board of Regents, The University of Texas System Esters of 2-deoxy-monosaccharides with anti proliferative activity

Also Published As

Publication number Publication date
JP2016515627A (ja) 2016-05-30
HUE056881T2 (hu) 2022-03-28
EP2981270A4 (en) 2017-01-04
US10201554B2 (en) 2019-02-12
US11026960B2 (en) 2021-06-08
EP2981270B1 (en) 2021-08-25
EP2981270A2 (en) 2016-02-10
US20190224225A1 (en) 2019-07-25
US20160184336A1 (en) 2016-06-30
WO2014165736A2 (en) 2014-10-09
US11925654B2 (en) 2024-03-12
EP3939595A1 (en) 2022-01-19
JP6545660B2 (ja) 2019-07-17
US20220023326A1 (en) 2022-01-27
WO2014165736A3 (en) 2014-11-27
ES2897699T3 (es) 2022-03-02

Similar Documents

Publication Publication Date Title
IL243225B (en) Self-injecting syringe
IL243224A0 (en) Self-injecting syringe
IL243360A0 (en) Methods for regulating the activity of cftr
GB2523869B (en) Representation of unstructured grids
PT3080100T (pt) Inibidores de desmetilase-1 específica de lisina
ZA201507110B (en) Crystal modifications of elobixibat
GB201321123D0 (en) Amplification of circular molecules
PL2997117T3 (pl) Zastosowanie estru
IL252547A0 (en) Treatment of multiple sclerosis using laquinimod
IL279291A (en) Morphic forms of hexadecyloxypropyl-phosphonate esters
IL244507B (en) A consequence of an insulin analogue
EP2951761A4 (en) GRAPHICS OF ACTIVITIES
GB201300276D0 (en) Photo-detector
IL240014A0 (en) Treatment of multiple sclerosis using laquinimod
ZA201602831B (en) Use of lactones
GB201321078D0 (en) Syringe assemblies
IL242491B (en) Consequences of glycinamide a-transformed
AP2015008645A0 (en) Methods of handling papaya
PL2981270T3 (pl) Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym
SG11201602693QA (en) Methods and intermediates for preparing macrolactams
TWM476829U (en) Structure of grille
TWM475821U (en) Structure of mosquito-catch
IL224699A0 (en) Protection of buildings
GB201301975D0 (en) New method for the purpose of safening
TWM475524U (en) Structure of rivet-pulling